Related Experiment Videos
Type I insulin-like growth factor receptor function in breast cancer
E Surmacz1, M A Guvakova, M K Nolan
1Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA. surmacz1@jeflin.tju.edu
Breast Cancer Research and Treatment
|March 27, 1998
Summary
The type I IGF receptor (IGF-IR) plays a key role in breast cancer growth and survival. While its exact role in metastasis is unclear, high IGF-IR levels may promote tumor progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Endocrinology
Background:
- Type I IGF receptor (IGF-IR) is implicated in breast cancer development.
- IGF-IR is overexpressed in breast tumors compared to normal tissue.
- IGF-IR ligands promote cancer cell proliferation and survival.
Purpose of the Study:
- To investigate the role of IGF-IR in breast cancer.
- To understand IGF-IR's involvement in cell motility, adhesion, and proliferation.
- To explore the cross-talk between IGF-IR and estrogen receptor (ER) signaling.
Main Methods:
- Analysis of IGF-IR expression in breast tumors and cell lines.
- Studies on IGF-IR ligands' effects on cell growth and apoptosis.
- Investigation of IGF-IR's role in cell aggregation and survival in 3D culture.
- Examination of humoral factor modulation of IGF-IR.
Main Results:
- Overexpression of IGF-IR in MCF-7 cells enhances E-cadherin-dependent cell aggregation, proliferation, and survival.
- IGF-IR signaling is modulated by estrogen, progesterone, IGF-II, and IL-1.
- IGF-IR and ER are co-expressed and functionally interact to control proliferation.
Conclusions:
- IGF-IR is a significant factor in breast cancer proliferation, survival, and potentially tumor mass increase.
- The precise role of IGF-IR in metastatic progression requires further investigation.
- Associations between IGF-IR and prognostic parameters in breast cancer are not fully documented, beyond ER status.